United States

Catalyst Biosciences is a biopharmaceutical company focused on developing protease product candidates for hemostasis and complement regulation. Their platform creates improved molecules to treat diseases resulting from complement system dysregulation. They are developing treatments for dry age-related macular degeneration and deficiencies in complement factor I. They also have platforms targeting other complement or inflammatory disorders. They have collaborations with Mosaic Biosciences and Biogen International. Founded in 2002, Catalyst Biosciences is headquartered in South San Francisco.

Catalyst Bioscience

Developing protease products for diseases.

Google

Quản lý Sản phẩm

Chuyên gia Dữ liệu

Catalyst Bioscience

Catalyst Bioscience Vị trí đang tuyển

Bạn đã sẵn sàng thăng tiến sự nghiệp? Hãy xem các vị trí đang mở tại Catalyst Bioscience.